Seagate Technology Reports Disappointing Earnings for Q2 2025
January 23, 2025 - 13:33
Seagate Technology Holdings has released its financial results for the second quarter of 2025, revealing a mixed performance that has raised concerns among investors. The company reported revenue of $2.33 billion, marking a significant increase of 50% compared to the previous year. However, the earnings per share (EPS) fell short of analysts' expectations, leading to a decline in the company's stock price.
The increase in revenue can be attributed to strong demand for data storage solutions, particularly in the cloud and enterprise sectors. Despite the positive revenue growth, the EPS miss has sparked discussions about the company's cost management strategies and overall profitability. Analysts had anticipated a more robust performance, and the shortfall could prompt a reevaluation of future earnings projections.
As the technology landscape continues to evolve, Seagate faces challenges in maintaining its competitive edge. Investors will be closely monitoring the company's strategic initiatives and market positioning in the coming quarters to better understand its path forward.
MORE NEWS
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...